I don't have much respect for the brokerage house Harleys but in a research report released Friday they rate Novogen a buy.
They have a valuation over $4 for the stock and cited positive developments in its drugs pipeline keys to the buy rating.
Cure for Cancer, here we come.
Novogen rated a buy by Hartleys
Add KZA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.035(5.60%) |
Mkt cap ! $88.89M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 66.5¢ | 62.0¢ | $20.15K | 31.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50574 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 13978 | 2 |
View Market Depth
| Last trade - 13.52pm 24/06/2022 (20 minute delay) ? |
 (live)
|
|||||
|
Last
66.0¢ |
Change
0.035 ( 5.60 %) |
||||
| Open | High | Low | Volume | ||
| 64.5¢ | 66.0¢ | 64.5¢ | 2006 | ||
| Last updated 12.09pm 24/06/2022 (live) ? | |||||
| KZA (ASX) Chart |